Balloon angioplasty for patients with minor strokes caused by narrowed brain arteries
Official title: Balloon Angioplasty for Minor Unstable Stroke With IntraCranial Atherosclerosis Stenosis (BAMUS-ICAS): a Prospective, Randomized, Multi-center Study
Run by General Hospital of Shenyang Military Region · NCT06763458 · Data updated 2026-11-12
This study is testing if a procedure called balloon angioplasty can help people who have had minor strokes from narrowed brain arteries feel better and prevent more strokes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | General Hospital of Shenyang Military Region Academic / other |
| Locations | 1 site (Shenyang) |
| Status | Recruiting |
| Started | February 19, 2025 |
| Main results expected | September 30, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | April 27, 2026 |
| Trial ID | NCT06763458 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 who have experienced a minor ischemic stroke within the past week and have severe stenosis due to intracranial atherosclerosis.
✕Probably not a fit
Patients with large intracranial vessel occlusion or those who have developed intracranial hemorrhagic disease will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the use of submaximal balloon angioplasty (SBA) as a treatment for patients experiencing minor ischemic strokes due to intracranial atherosclerotic stenosis (ICAS). The study focuses on patients who have not responded adequately to medical management and are at risk of early neurological deterioration. By improving blood flow through SBA, the trial aims to enhance patient outcomes and reduce the risk of further complications. Participants will be closely monitored for changes in their neurological status following the intervention.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of early neurological deterioration in patients with minor strokes caused by ICAS.
How similar studies have gone: While the use of balloon angioplasty in stroke management is not widely tested, preliminary approaches suggest potential benefits, making this study a novel exploration in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Over 18 years of age; 2. Minor ischemic stroke within 1 week of onset (NIHSS≤5); 3. Have received the best drug treatment (dual antibody, anti-plate combined with anticoagulation), but symptoms still have measurable fluctuations or progression (NIHSS increased by at least 1 point); 4. Symptoms fluctuate to the time of receiving balloon dilation within 24 hours; 5. The etiology was considered to be severe stenosis of the responsible vessels due to intracranial arteriosclerosis (70-99% stenosis), or perforator artery disease with severe stenosis of the carrier artery (confirmed by MRA, CTA or DSA); 6. Patients with first onset or past onset without sequelae such as limb paralysis should not affect the score of this NIHSS, and mRS Score of patients with past onset should be less than 2 points; 7. Patients or family members sign informed consent. Exclusion Criteria: 1. Patients who have developed large intracranial vessel occlusion; 2. Intracranial hemorrhagic diseases in the past 3 months: cerebral hemorrhage, subarachnoid hemorrhage, etc.; 3. Non-atherosclerotic disease-related stenosis: arterial dissection, moya-moya disease, arterioinflammatory disease, etc. 4. Clotting disorders or systemic bleeding tendency or platelets less than 100,000; 5. Complicated with serious infection or liver, kidney and other serious diseases; 6. Patients with severe inability to control hypertension (systolic blood pressure \>200mmHg or diastolic blood pressure \>110mmHg); 7. Women who are pregnant, have a pregnancy plan or are breastfeeding; 8. Complicated with other serious diseases, life expectancy \< 6 months; Other conditions deemed inappropriate for participation in this study.
Where it's running
-
General Hospital of Northern Theater Command
Shenyang, China Recruiting
Study contacts
- Study coordinator: Hui-Sheng Chen
- Email: chszh@aliyun.com
- Phone: +86-024-28897511
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
-
Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)
This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
-
Photon-counting CT to check intracranial stents
This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.